Greenwoods Asset Management Hong Kong Ltd. Takes $55.61 Million Position in SPDR S&P Biotech ETF $XBI

Greenwoods Asset Management Hong Kong Ltd. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 555,015 shares of the exchange traded fund’s stock, valued at approximately $55,613,000. SPDR S&P Biotech ETF accounts for 1.3% of Greenwoods Asset Management Hong Kong Ltd.’s holdings, making the stock its 18th biggest position. Greenwoods Asset Management Hong Kong Ltd. owned approximately 0.91% of SPDR S&P Biotech ETF at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of XBI. JPMorgan Chase & Co. increased its stake in SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Bessemer Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 9.3% during the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after purchasing an additional 138,322 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the last quarter. Meitav Investment House Ltd. grew its holdings in shares of SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after purchasing an additional 281,602 shares during the last quarter. Finally, Greenhouse Funds LLLP increased its stake in SPDR S&P Biotech ETF by 17.3% in the 2nd quarter. Greenhouse Funds LLLP now owns 579,667 shares of the exchange traded fund’s stock worth $48,072,000 after buying an additional 85,422 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $124.78 on Friday. The firm has a market capitalization of $8.34 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $132.09. The company has a 50-day moving average of $124.65 and a 200 day moving average of $111.08.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.